The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
Public ClinicalTrials.gov record NCT01990092. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objectives of the MEDIAN study are to evaluate the short-term and long-term safety and nutritional benefits of Metanx® versus placebo in subjects with mild to moderate diabetic peripheral neuropathy (DPN). Short-term effects will be evaluated during the first 16 weeks of treatment, and long-term effects will be evaluated over the duration of a 48 week treatment period.
Study identification
- NCT ID
- NCT01990092
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 238 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 25 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2013
- Primary completion
- Jul 31, 2016
- Completion
- Feb 28, 2018
- Last update posted
- Jan 17, 2016
2013 – 2018
United States locations
- U.S. sites
- 25
- U.S. states
- 13
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Coastal Clinical Research, Inc. | Mobile | Alabama | 36608 | — |
| Arizona Research Center | Phoenix | Arizona | 85023 | — |
| Clinical Trials, Inc. | Little Rock | Arkansas | 72205 | — |
| Collaborative Neuroscience Network, LLC | Long Beach | California | 90806 | — |
| Center for Clinical Research, Inc. | San Francisco | California | 94115 | — |
| Coastal Connecticut Research, LLC | New London | Connecticut | 06320 | — |
| Meridien Research | Bradenton | Florida | 34208 | — |
| PAB Clinical Research | Brandon | Florida | 33511 | — |
| Suncoast Clinical Research, Inc. | New Port Richey | Florida | 34652 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Suncoast Clinical Research | Palm Harbor | Florida | 34684 | — |
| Florida Medical Clinic | Wesley Chapel | Florida | 33544 | — |
| North Chattahoochee Family Physicians, LLC | Johns Creek | Georgia | 30097 | — |
| Willis-Knighton Physician Network / WKB Family Medicine Associates | Bossier City | Louisiana | 71111 | — |
| Tulane University School of Medicine | New Orleans | Louisiana | 70112 | — |
| Urgent Care Specialists, LLC dba Hometown Urgent Care & Occupational Health | Dayton | Ohio | 45424 | — |
| CRI Lifetree | Philadelphia | Pennsylvania | 19139 | — |
| Trinity Clinical Research, LLC | Tullahoma | Tennessee | 37388 | — |
| FutureSearch Trials of Neurology, L.P. | Austin | Texas | 78731 | — |
| Centex Studies Inc. | Houston | Texas | 77062 | — |
| Pioneer Research Solutions, Inc. | Houston | Texas | 77098 | — |
| Endeavor Clinical Trials, PA | San Antonio | Texas | 78229 | — |
| Northeast Clinical Research of San Anotnio, LLC | Schertz | Texas | 78154 | — |
| ClinPoint Trials, LLC | Waxahachie | Texas | 75165 | — |
| Strelitz Diabetes Center | Norfolk | Virginia | 23510 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Diabetic Peripheral Neuropathy trials
Other public records listing Diabetic Peripheral Neuropathy. Sorted by last update posted; newest first. Not a recommendation.
- NCT06287736: Spinal Cord Stimulation and Small Fiber Peripheral Neuropathy Recruiting
- NCT05965336: Walking Function in Diabetic Peripheral Neuropathy Recruiting
- NCT07260656: Efficacy of a Topical Palmitated Formulation of Capsaicin (Capsadyn®) In the Treatment of Diabetic Neuropathic Foot Pain Recruiting
- NCT06591780: Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy Recruiting
- NCT04658693: Functional and Neuroprotective Effects of Restoring Lower Limb Sensation After Diabetic Peripheral Neuropathy Recruiting
- NCT06797869: A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01990092, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 17, 2016 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01990092 live on ClinicalTrials.gov.